Skip to main content
Download PDF
Download ePub
  • Retraction Note
  • Open access
  • Published:

Retraction Note: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer

Journal of Experimental & Clinical Cancer Research volume 44, Article number: 38 (2025) Cite this article

The Original Article was published on 28 May 2013

Retraction Note: J Exp Clin Cancer Res32, 32 (2013)

https://doiorg.publicaciones.saludcastillayleon.es/10.1186/1756-9966-32-32

The Editor-in-Chief has retracted this article. After publication, concerns were raised regarding high similarity among the MMP-9 DMSO, Gibenclamide, and Paclitaxel images in Fig. 2B.

Due to the severity of these concerns in the context of the article, the Editor-in-Chief no longer has confidence in the presented data.

None of the authors have responded to any correspondence from the Publisher about this retraction.

Author information

Authors and Affiliations

  1. Department of Basic Medicine & Experimental Technology, Division of Clinical Medicine, Logistic University of Chinese People’s Armed Police Force, Tianjin, 300162, P. R. China

    Zhe Rong

  2. Department of Pathology, Anhui Medical University, Hefei, 230032, Anhui Province, P. R. China

    Li Li, Fei Fei & Lailong Luo

  3. Department of Neurosurgery, Logistic University Affiliated Hospital, Logistic University of Chinese People’s Armed Police Force, Tianjin, 300162, P. R. China

    Yang Qu

Authors
  1. Zhe Rong
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Li Li
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Fei Fei
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Lailong Luo
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Yang Qu
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Zhe Rong.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doiorg.publicaciones.saludcastillayleon.es/10.1186/1756-9966-32-32.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rong, Z., Li, L., Fei, F. et al. Retraction Note: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer. J Exp Clin Cancer Res 44, 38 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13046-025-03311-z

Download citation

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13046-025-03311-z

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us